Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
ClinicalTrials.gov study NCT01398592. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
ClinicalTrials.gov study NCT02099110. IPD Sharing: YES. Countries: 0. Publications: 8.
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
ClinicalTrials.gov study NCT00885352. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
ClinicalTrials.gov study NCT01936025. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
ClinicalTrials.gov study NCT01076088. IPD Sharing: YES. Countries: 0. Publications: 1.
Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT05167513. IPD Sharing: NO. Countries: 1. Publications: 1.
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
ClinicalTrials.gov study NCT00372060. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
ClinicalTrials.gov study NCT01582308. IPD Sharing: YES. Countries: 0. Publications: 1.
Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
ClinicalTrials.gov study NCT00978796. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
ClinicalTrials.gov study NCT00350779. IPD Sharing: YES. Countries: 0. Publications: 1.
Randomized Sitagliptin Withdrawal Study (MK-0431-845)
ClinicalTrials.gov study NCT02738879. IPD Sharing: YES. Countries: 0. Publications: 1.
Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
ClinicalTrials.gov study NCT00305604. IPD Sharing: YES. Countries: 0. Publications: 1.
The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy
ClinicalTrials.gov study NCT06115460. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
ClinicalTrials.gov study NCT00541775. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Sitagliptin in the Elderly
ClinicalTrials.gov study NCT00451113. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
ClinicalTrials.gov study NCT00541450. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D
ClinicalTrials.gov study NCT02607410. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
ClinicalTrials.gov study NCT00813995. IPD Sharing: YES. Countries: 0. Publications: 1.
Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT02173457. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Con
ClinicalTrials.gov study NCT01841697. IPD Sharing: YES. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.